You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: May 15, 2024

MEMBRANEBLUE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Membraneblue patents expire, and what generic alternatives are available?

Membraneblue is a drug marketed by Dorc and is included in one NDA.

The generic ingredient in MEMBRANEBLUE is trypan blue. There are two drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the trypan blue profile page.

Summary for MEMBRANEBLUE
US Patents:0
Applicants:1
NDAs:1
Raw Ingredient (Bulk) Api Vendors: 40
Formulation / Manufacturing:see details
What excipients (inactive ingredients) are in MEMBRANEBLUE?MEMBRANEBLUE excipients list
DailyMed Link:MEMBRANEBLUE at DailyMed
Drug patent expirations by year for MEMBRANEBLUE
Anatomical Therapeutic Chemical (ATC) Classes for MEMBRANEBLUE

US Patents and Regulatory Information for MEMBRANEBLUE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Dorc MEMBRANEBLUE trypan blue SOLUTION;OPHTHALMIC 022278-001 Feb 20, 2009 DISCN Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing